HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sophie Georgin-Lavialle Selected Research

Hereditary Autoinflammatory Diseases

1/2021Real-Life Indications of Interleukin-1 Blocking Agents in Hereditary Recurrent Fevers: Data From the JIRcohort and a Literature Review.
1/2020Long-Term Follow-Up and Optimization of Interleukin-1 Inhibitors in the Management of Monogenic Autoinflammatory Diseases: Real-Life Data from the JIR Cohort.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sophie Georgin-Lavialle Research Topics

Disease

15Familial Mediterranean Fever (Periodic Disease)
05/2021 - 01/2017
13Amyloidosis
09/2022 - 10/2014
11Inflammation (Inflammations)
12/2021 - 01/2017
9Mastocytosis
06/2016 - 03/2010
6Fever (Fevers)
04/2021 - 11/2010
5COVID-19
04/2022 - 01/2021
5Infections
01/2022 - 07/2015
4Autoimmune Diseases (Autoimmune Disease)
10/2022 - 01/2020
4VEXAS syndrome
01/2022 - 10/2021
4Arthralgia (Joint Pain)
10/2021 - 01/2011
4Neoplasms (Cancer)
06/2021 - 07/2015
4Rheumatoid Arthritis
06/2021 - 08/2010
4Mevalonate Kinase Deficiency
01/2021 - 01/2018
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2022 - 01/2019
3Necrosis
12/2021 - 10/2019
3Chronic Kidney Failure (Chronic Renal Failure)
06/2021 - 04/2021
3Congenital heart block
12/2017 - 10/2004
2Proteinuria
11/2022 - 10/2014
2Cryopyrin-Associated Periodic Syndromes
11/2022 - 01/2020
2Neonatal Systemic lupus erythematosus
10/2022 - 12/2015
2Musculoskeletal Diseases (Musculoskeletal Disease)
07/2022 - 06/2021
2autosomal dominant familial Periodic fever
12/2021 - 01/2021
2Immunoglobulin Light-chain Amyloidosis
11/2021 - 10/2014
2Splenomegaly
10/2021 - 01/2014
2Hereditary Autoinflammatory Diseases
01/2021 - 01/2020
2Anemia
01/2019 - 06/2016
2Arthritis (Polyarthritis)
12/2018 - 07/2015
2Erdheim-Chester Disease
03/2013 - 11/2010
2Systemic Mastocytosis
01/2013 - 07/2012
2Connective Tissue Diseases (Connective Tissue Disease)
01/2011 - 10/2004
1Pneumonia (Pneumonitis)
04/2022
1Gout
03/2022
1Neurologic Manifestations (Neurological Manifestations)
01/2022
1Paraproteinemias (Monoclonal Gammopathy)
11/2021
1Sweet Syndrome (Acute Febrile Neutrophilic Dermatosis)
11/2021
1Reinfection
06/2021
1Persistent Infection
06/2021
1Acute-Phase Reaction
06/2021
1Cardiovascular Diseases (Cardiovascular Disease)
06/2021
1Hypertension (High Blood Pressure)
06/2021
1Interstitial Lung Diseases (Interstitial Lung Disease)
06/2021
1Goiter
05/2021
1Serositis
04/2021
1Nephrotic Syndrome (Syndrome, Nephrotic)
04/2021
1Pain (Aches)
04/2021
1Hyper-IgM Immunodeficiency Syndrome (Hyper-IgM Syndrome)
01/2021
1Disease Progression
01/2021
1Chronic Granulomatous Disease
01/2021
1Chronic Renal Insufficiency
01/2021
1Job Syndrome (Hyper-IgE Syndrome)
01/2021
1Pericarditis
01/2021
1Hashimoto Disease (Thyroiditis, Hashimoto)
01/2021
1Aphthous Stomatitis (Aphthous Ulcer)
01/2021
1Abdominal Pain (Pain, Abdominal)
01/2021

Drug/Important Bio-Agent (IBA)

16AA amyloidosisIBA
11/2022 - 10/2014
8Interleukin-1 (Interleukin 1)IBA
11/2022 - 11/2010
7Amyloid (Amyloid Fibrils)IBA
09/2022 - 11/2018
7ColchicineFDA LinkGeneric
04/2021 - 01/2017
7Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2021 - 03/2013
6Biological ProductsIBA
11/2021 - 07/2010
5AntibodiesIBA
10/2022 - 10/2004
5EnzymesIBA
01/2022 - 06/2016
5InterleukinsIBA
05/2021 - 01/2015
3Adrenal Cortex Hormones (Corticosteroids)IBA
01/2022 - 01/2011
3Proteins (Proteins, Gene)FDA Link
06/2021 - 03/2017
3InflammasomesIBA
01/2020 - 01/2017
3Interleukin-6 (Interleukin 6)IBA
10/2019 - 11/2010
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2018 - 06/2015
3C-Reactive ProteinIBA
01/2018 - 11/2010
2Prealbumin (Transthyretin)IBA
09/2022 - 10/2014
2Dexamethasone (Maxidex)FDA LinkGeneric
04/2022 - 01/2015
2Azacitidine (5 Azacytidine)FDA Link
01/2022 - 11/2021
2Immunoglobulins (Immunoglobulin)IBA
11/2021 - 01/2021
2Rituximab (Mabthera)FDA Link
06/2021 - 01/2015
2Biomarkers (Surrogate Marker)IBA
04/2021 - 02/2019
2Phosphotransferases (Kinase)IBA
01/2021 - 05/2014
2canakinumabFDA Link
01/2021 - 01/2020
2AutoantibodiesIBA
01/2020 - 02/2019
2Tryptophan (L-Tryptophan)FDA Link
01/2019 - 01/2016
2Tyrosine Kinase InhibitorsIBA
01/2016 - 07/2012
2Tryptases (Tryptase)IBA
01/2014 - 01/2013
2Telomerase (Telomerase Reverse Transcriptase)IBA
01/2014 - 08/2010
2masitinibIBA
07/2012 - 01/2011
1AmyloseIBA
09/2022
1VaccinesIBA
07/2022
1Oxygen (Dioxygen)IBA
04/2022
1tocilizumab (atlizumab)FDA Link
04/2022
1UbiquitinIBA
01/2022
1Ubiquitin-Activating Enzymes (Ubiquitin-Activating Enzyme)IBA
11/2021
1Ferritins (Ferritin)IBA
10/2021
1Serum Amyloid A Protein (Serum Amyloid A)IBA
06/2021
1Anti-Bacterial Agents (Antibiotics)IBA
06/2021
1Antinuclear AntibodiesIBA
01/2021
1Pharmaceutical PreparationsIBA
01/2021
1remdesivirIBA
01/2021

Therapy/Procedure

9Therapeutics
01/2022 - 01/2011
1Artificial Respiration (Mechanical Ventilation)
04/2022
1Length of Stay
01/2022
1Thyroidectomy
05/2021
1Renal Dialysis (Hemodialysis)
05/2021